TELLURIAN INC (TELL)

US87968A1043 - Common Stock

0.999  +0 (+0.16%)

After market: 0.9994 +0 (+0.04%)

Fundamental Rating

2

Taking everything into account, TELL scores 2 out of 10 in our fundamental rating. TELL was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. TELL may be in some trouble as it scores bad on both profitability and health. TELL is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

TELL had negative earnings in the past year.
In the past year TELL has reported a negative cash flow from operations.
In the past 5 years TELL always reported negative net income.
In the past 5 years TELL always reported negative operating cash flow.

1.2 Ratios

TELL has a Return On Assets of -27.97%. This is amonst the worse of the industry: TELL underperforms 95.63% of its industry peers.
The Return On Equity of TELL (-47.38%) is worse than 90.78% of its industry peers.
Industry RankSector Rank
ROA -27.97%
ROE -47.38%
ROIC N/A
ROA(3y)-11.5%
ROA(5y)-29.22%
ROE(3y)-20.48%
ROE(5y)-69.16%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TELL's Gross Margin of 51.26% is in line compared to the rest of the industry. TELL outperforms 54.85% of its industry peers.
TELL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TELL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.24%
GM growth 5Y5.33%

More info and screens

1

2. Health

2.1 Basic Checks

TELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TELL has more shares outstanding
The number of shares outstanding for TELL has been increased compared to 5 years ago.
TELL has a better debt/assets ratio than last year.

2.2 Solvency

TELL has an Altman-Z score of -1.01. This is a bad value and indicates that TELL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.01, TELL is not doing good in the industry: 75.24% of the companies in the same industry are doing better.
TELL has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
TELL has a Debt to Equity ratio (0.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -1.01
ROIC/WACCN/A
WACC6.22%

2.3 Liquidity

A Current Ratio of 0.27 indicates that TELL may have some problems paying its short term obligations.
TELL has a worse Current ratio (0.27) than 92.72% of its industry peers.
TELL has a Quick Ratio of 0.27. This is a bad value and indicates that TELL is not financially healthy enough and could expect problems in meeting its short term obligations.
TELL's Quick ratio of 0.27 is on the low side compared to the rest of the industry. TELL is outperformed by 92.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27

More info and screens

5

3. Growth

3.1 Past

TELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -184.62%.
Looking at the last year, TELL shows a very negative growth in Revenue. The Revenue has decreased by -68.79% in the last year.
Measured over the past years, TELL shows a very strong growth in Revenue. The Revenue has been growing by 74.42% on average per year.
EPS 1Y (TTM)-184.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)-68.79%
Revenue growth 3Y64.34%
Revenue growth 5Y74.42%
Sales Q2Q%-51.14%

3.2 Future

Based on estimates for the next years, TELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.27% on average per year.
Based on estimates for the next years, TELL will show a very strong growth in Revenue. The Revenue will grow by 47.98% on average per year.
EPS Next Y37.1%
EPS Next 2Y16%
EPS Next 3Y10.63%
EPS Next 5Y9.27%
Revenue Next Year-78.31%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y47.98%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TELL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16%
EPS Next 3Y10.63%

More info and screens

0

5. Dividend

5.1 Amount

TELL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TELLURIAN INC

NYSEARCA:TELL (10/8/2024, 8:26:44 PM)

After market: 0.9994 +0 (+0.04%)

0.999

+0 (+0.16%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-08 2024-08-08/amc
Earnings (Next)10-30 2024-10-30/amc
Inst Owners49.41%
Inst Owner Change90.83%
Ins Owners9.09%
Ins Owner Change-23.51%
Market Cap892.99M
Analysts48
Price Target1.19 (19.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-157.35%
Min EPS beat(2)-316.67%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-87.26%
Min EPS beat(4)-316.67%
Max EPS beat(4)55.44%
EPS beat(8)4
Avg EPS beat(8)81.3%
EPS beat(12)6
Avg EPS beat(12)-7.84%
EPS beat(16)7
Avg EPS beat(16)-9.28%
Revenue beat(2)0
Avg Revenue beat(2)-25.26%
Min Revenue beat(2)-31.92%
Max Revenue beat(2)-18.61%
Revenue beat(4)0
Avg Revenue beat(4)-27.4%
Min Revenue beat(4)-38.64%
Max Revenue beat(4)-18.61%
Revenue beat(8)1
Avg Revenue beat(8)-22.96%
Revenue beat(12)4
Avg Revenue beat(12)4.36%
Revenue beat(16)6
Avg Revenue beat(16)8.86%
PT rev (1m)0%
PT rev (3m)-29.94%
EPS NQ rev (1m)-28.57%
EPS NQ rev (3m)5.26%
EPS NY rev (1m)0%
EPS NY rev (3m)1.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-53.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.73
P/FCF N/A
P/OCF N/A
P/B 1.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.09
BVpS0.62
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.97%
ROE -47.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.26%
FCFM N/A
ROA(3y)-11.5%
ROA(5y)-29.22%
ROE(3y)-20.48%
ROE(5y)-69.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.24%
GM growth 5Y5.33%
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 181.35%
Cap/Sales 195.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -1.01
F-Score2
WACC6.22%
ROIC/WACCN/A
Cap/Depr(3y)646.86%
Cap/Depr(5y)390.79%
Cap/Sales(3y)130.68%
Cap/Sales(5y)80.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-184.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y37.1%
EPS Next 2Y16%
EPS Next 3Y10.63%
EPS Next 5Y9.27%
Revenue 1Y (TTM)-68.79%
Revenue growth 3Y64.34%
Revenue growth 5Y74.42%
Sales Q2Q%-51.14%
Revenue Next Year-78.31%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y47.98%
EBIT growth 1Y-39.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.65%
EBIT Next 3Y0.41%
EBIT Next 5Y25.91%
FCF growth 1Y22.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.26%
OCF growth 3YN/A
OCF growth 5YN/A